Kate Therapeutics

Series-A Acquired by Novartis
katetherapeutics.com Biotech & Healthcare San Diego, United States Founded 2020 11-50
Total Funding $51M
Latest Round $51M Series-A
Last Announced Jun 8, 2023
Investors 4 Backers
Decision Makers 4 Verified

About Kate Therapeutics

Kate Therapeutics is a biotechnology company focused on developing next-generation gene therapies for muscle and heart diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters San Diego, United States
Year Founded 2020
Team Size 11-50
Corporate Status Acquired by Novartis
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website katetherapeutics.com
Domain Registered Date Sep 5, 2020

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $51,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    katetherapeutics.com

  3. Milestone

    Company founded

    San Diego, United States

Investors & Backers

4
OUP (Osage University Partners)
UF Innovate Ventures
Versant Ventures
Westlake Village BioPartners

Funding History

1 Round
Series-A · Jun 8, 2023

Founders & Leadership

3

Kevin Forrest

Founder

Work email & phone locked Unlock →

Mark Fielden

Founder

Work email & phone locked Unlock →

Sharif Tabebordbar

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts